Amedeo Smart

Free Medical Literature Service

 

Amedeo

Bladder Cancer
  Free Subscription

Articles published in
Prog Urol
    December 2023
  1. GALLON J, LeMaoult J, Verine J, Dumont C, et al
    [Profile and immune environment of upper tract urothelial carcinoma].
    Prog Urol. 2023;33.
    >> Share

  2. BRUNEAUX E, Iborra F, Trouche-Sabatier SG, Foucan AS, et al
    [Bladder tumors in the Herault department: Results of the Herault tumor registry registration from1987 to 2019].
    Prog Urol. 2023;33.
    >> Share

    November 2023
  3. ARNAUD Q, Sebe P, Colau A, Mouton M, et al
    Management of high-grade papillary Ta or T1 bladder cancer after restaging transurethral resection: A retrospective study comparing Bacillus Calmette-Guerin therapy upfront versus a third resection.
    Prog Urol. 2023 Nov 16:S1166-7087(23)00238-5. doi: 10.1016/j.purol.2023.
    >> Share

    August 2023
  4. GABRIEL PE, Lambert T, Dumont C, Gauthier H, et al
    [Preoperative chemotherapy for patients with upper tract urothelial carcinoma: Impact on renal function].
    Prog Urol. 2023;33.
    >> Share

    April 2023
  5. SOOROJEBALLY Y, Neuzillet Y, Lebret T, Allory Y, et al
    Photodynamic cystoscopy for bladder cancer diagnosis and for NMIBC follow-up: An overview of systematic reviews and meta-analyses.
    Prog Urol. 2023 Apr 21:S1166-7087(23)00083-0. doi: 10.1016/j.purol.2023.
    >> Share

    March 2023
  6. CIMIER A, Thach S, Lacroix B, Mariat C, et al
    [Evaluation of the efficacy and safety of HIVEC intravesical thermochemotherapy with intermediate-risk and high-risk non-muscle-invasive bladder cancer].
    Prog Urol. 2023 Mar 9:S1166-7087(23)00062-3. doi: 10.1016/j.purol.2023.
    >> Share

  7. GABRIEL PE, Pinar U, Parra J, Vaessen C, et al
    [Pathological pelvic lymph node involvement in muscle-invasive bladder cancer patients treated with radical cystectomy: A narrative review].
    Prog Urol. 2023;33:145-154.
    >> Share

    February 2023
  8. AUDENET F, Neuzillet Y, Roupret M
    [Photodynamic-guided transurethral resection: Uncertainties brought to light].
    Prog Urol. 2023;33:56-57.
    >> Share

    January 2023
  9. BRUN A, Koutlidis N, Thibault T, Escoffier A, et al
    [The impact of restaging transurethral resection on recurrence and progression free survival in patients with T1 high grade bladder cancer].
    Prog Urol. 2023 Jan 3:S1166-7087(22)00537-1. doi: 10.1016/j.purol.2022.
    >> Share

    November 2022
  10. NEUZILLET Y, Audenet F, Loriot Y, Allory Y, et al
    French AFU Cancer Committee Guidelines - Update 2022-2024: Muscle-Invasive Bladder Cancer (MIBC).
    Prog Urol. 2022;32:1141-1163.
    >> Share

  11. NEUZILLET Y, Pradere B, Xylinas E, Allory Y, et al
    French AFU Cancer Committee Guidelines - Update 2022-2024: Non-muscle-invasive bladder cancer (NMIBC).
    Prog Urol. 2022;32:1102-1140.
    >> Share

    May 2022
  12. DOBE TR, Belhadj Y, Michel C, Djouadou M, et al
    Perioperative results of radical cystectomy after neoadjuvant chemotherapy according to the implementation of ERAS pathway.
    Prog Urol. 2022;32:401-409.
    >> Share

  13. EL AZAB A, Hossam E, Abdelrahman I, Aboulkassem H, et al
    Variables affecting quality of life after Radical cystectomy and neobladder substitution: Egyptian National Cancer Institute experience.
    Prog Urol. 2022;32:410-418.
    >> Share

    April 2022
  14. ROLLIN P, Xylinas E, Lanz C, Audenet F, et al
    [Intravesical adjuvant regimen of epitubicin for intermediate risk NMIBC: Feasability study from CC-AFU vessie].
    Prog Urol. 2022;32:326-331.
    >> Share

    March 2022
  15. AUDENET F, Sotto A, Roumiguie M, Allory Y, et al
    [Guidelines from the cancer (CC-AFU) and infection disease (CI-AFU) committees of the French Association of Urology for the management of adverse events and complications of BCG].
    Prog Urol. 2022;32:165-176.
    >> Share

    February 2022
  16. LEON P, Saint F, Audenet F, Roumiguie M, et al
    [Guidelines from the cancer committee of the French Association of Urology (CC-AFU) for adequate intravesical instillations of Mitomycin C, Epirubicin, and BCG for non-muscle invasive bladder cancer].
    Prog Urol. 2022 Feb 9. pii: S1166-7087(22)00011.
    >> Share

    January 2022
  17. MESSAOUD M, Vercherin P, Chaneliere AF, Mottet N, et al
    [Geriatric assessment and treatment of nonmetastatic muscle-invasive bladder cancer in patients over 75 years of age. Retrospective and multicentric study of 121 cases].
    Prog Urol. 2022 Jan 5. pii: S1166-7087(21)00582.
    >> Share

  18. SOOROJEBALLY Y, Surlemont L, Neuzillet Y, Lebret T, et al
    Impact of carcinoma in situ on survival of patients treated by adjuvant chemotherapy after cystectomy.
    Prog Urol. 2022;32:53-60.
    >> Share

    September 2021
  19. ROUX S, Pettenati C, Dariane C, Sbizzera M, et al
    Management of long ureteral stenosis: Alternatives to indwelling ureteral stents.
    Prog Urol. 2021;31:598-604.
    >> Share

    August 2021
  20. CAMPAGNA J, Touzani R, Gravis G, Marino P, et al
    [Does the announcement of cancer at the time of Non Muscle-Invasive Bladder Cancer diagnosis affect quality of life and adherence of patients? Data from the French prospective cohort VICAN].
    Prog Urol. 2021 Aug 27. pii: S1166-7087(21)00213.
    >> Share

    May 2021
  21. SAINT F, Masson-Lecomte A
    Achieving disease free distal ureteral margin at the time of radical cystectomy: Why and for whom? (an overview of literature).
    Prog Urol. 2021;31:303-315.
    >> Share

  22. SURLEMONT L, Nouhaud FX, Dupuis H, Delcourt C, et al
    [BCG strain shortage from 2012 to 2014: Evaluation of its impact on the management of patients with high-risk NMIBC].
    Prog Urol. 2021;31:324-331.
    >> Share

    March 2021
  23. GONDRAN-TELLIER B, Abdallah R, Sichez PC, Akiki A, et al
    Continuous saline bladder irrigation after blue light transurethral resection of bladder tumor increases recurrence-free survival in low- to intermediate-risk non-muscle invasive bladder cancer.
    Prog Urol. 2021 Mar 1. pii: S1166-7087(21)00028.
    >> Share

    January 2021
  24. SUCH M, Lavolle A, Popelin MB, Thibault C, et al
    Administration of neoadjuvant chemotherapy for muscle-invasive bladder cancer in real life: Are urologists still too cautious?
    Prog Urol. 2021 Jan 16. pii: S1166-7087(20)30742.
    >> Share

    December 2020
  25. PIGNOT G, Sargos P
    [Adjuvant radiotherapy after radical cystectomy for muscle-invasive bladder cancer].
    Prog Urol. 2020 Dec 23. pii: S1166-7087(20)30741.
    >> Share

    November 2020
  26. ROUPRET M, Pignot G, Masson-Lecomte A, Comperat E, et al
    [French ccAFU guidelines - update 2020-2022: bladder cancer].
    Prog Urol. 2020;30.
    >> Share

    February 2020
  27. BIARDEAU X, Lamande N, Tondut L, Peyronnet B, et al
    Quality of life associated with orthotopic neobladder and ileal conduit in women: A multicentric cross-sectional study.
    Prog Urol. 2020;30:80-88.
    >> Share

    January 2020
  28. BRANCHU B, Leon P, Jeglinschi SC, Durlach A, et al
    [Interest of reTURB for pTa high grade bladder urothelial carcinoma].
    Prog Urol. 2020;30:19-25.
    >> Share

  29. CERF N, Radulescu C, Neuzillet Y, Rouanne M, et al
    [Usefulness of frozen section exams during radical cystectomy for urothelial carcinoma].
    Prog Urol. 2020;30:51-57.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016